Eczema drug interaction study completed – no cure, just safety data
NCT ID NCT05891119
First seen Jan 11, 2026 · Last updated May 15, 2026 · Updated 23 times
Summary
This early-phase study looked at how rocatinlimab changes the way the body processes certain other medications in 21 adults with moderate to severe atopic dermatitis (eczema). Participants received a cocktail of common drugs before and after rocatinlimab to measure differences in drug levels. The goal was to gather safety and interaction information, not to treat the disease. No direct benefit to participants was intended.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Accel Research Sites (ACR)
DeLand, Florida, 32720-3134, United States
-
Axis Clinicals, LCC
Dilworth, Minnesota, 56529, United States
-
DermDox Dermatology Centers, PC - Camp Hill
Camp Hill, Pennsylvania, 17011, United States
-
DermDox Dermatology Centers, PC - Sugarloaf
Nashville, Tennessee, 37203-1632, United States
-
Direct Helpers Research Center (DHRC)
Hialeah, Florida, 33012-3618, United States
-
Velocity Clinical Research -Spartanburg
Spartanburg, South Carolina, 29303-4225, United States
-
Velocity Clinical Research, North Hollywood
North Hollywood, California, 91606-1570, United States
Conditions
Explore the condition pages connected to this study.